XRP Adoption Expands to 6,000 US Pharmacies
Wellgistics Health incorporates XRP into its payment system across 6,000 US pharmacies, backed by a $50 million equity line from LDA Capital.
- Wellgistics Health launches XRP payments in pharmacies.
- Enhances speed, liquidity, and transparency in healthcare.
- XRP serves as payment and treasury asset.
The implementation highlights growing institutional interest in cryptocurrency, providing faster and cost-effective transactions. It marks a significant real-world application of blockchain technology in the healthcare sector.
Wellgistics Health Initiative
The initiative by Wellgistics Health, supported by a $50 million line of credit from LDA Capital, aims to transform healthcare payments with XRP’s integration. Wellgistics will use XRP to enhance payment speed and liquidity for 6,000 US pharmacies.
Brian Norton, CEO of Wellgistics Health, emphasizes the integration of blockchain technology to improve payment systems. The decision positions Wellgistics Health as a pioneering entity in healthcare, optimizing financial operations with XRP as a core asset.
“Our blockchain-enabled payment system and ledger is just the next logical step in healthcare evolution, allowing us to hardwire speed, liquidity, and transparency into a system that’s long been starved of all three.” — Brian Norton, CEO of Wellgistics Health
Implications for the Healthcare Industry
The payment transformation is expected to deliver real-time settlement, boosting efficiency in transactions between pharmacies, suppliers, and manufacturers. This move reflects growing interest in incorporating cryptocurrencies in traditional sectors.
XRP’s cost-effective framework, with less than $0.0002 per transaction, provides a stark contrast to traditional wire fees. Its integration proves advantageous for liquidity and financial control within pharmacy networks.
The broader implications could lead to increased adoption of XRP and similar technologies within the healthcare industry. While concerns regarding regulatory approval exist, the strategy could offer essential cost benefits and propel technological advances.
This initiative demonstrates how blockchain, through XRP, may continue influencing financial systems and operational efficiency. It highlights a potential shift in pharmaceutical distribution towards more scalable and agile financial frameworks.
More From Crypto News
Report Says ECB President Urged Blocking Binance EU License
A report claims ECB President Christine Lagarde personally urged European officials to block Binance from obtaining an EU-wide crypto license, a development tha...
Binance to Briefly Suspend Deposits and Withdrawals Next Week
Binance will suspend deposits and withdrawals across its platform on September 22, 2026 at 06:00 UTC as part of a scheduled infrastructure wallet system upgrade...
Bitcoin Rises to $81,000 After Bank of Japan Rate Hike
Bitcoin climbed to $81,000 on September 18, 2026, shortly after the Bank of Japan raised its benchmark interest rate to 1. 25%, adding another tightening step i...
Binance Launches 24/7 FX Perpetual Futures With 100x Leverage
Binance is set to launch its first foreign exchange perpetual futures contract, USDBRLUSDT, on September 21, 2026 at 14:00 UTC, giving traders around-the-clock...
Hyperliquid Opens Native Borrowing as HYPE Hits New High
Hyperliquid has launched native borrowing directly within its platform, allowing users to access liquidity without exiting their positions, while the HYPE token...
Bitcoin Tops $80,000 Ahead of Weak U.S. Economic Data
Bitcoin topped $80,000 on September 18, 2026, rising more than 5% over 24 hours as traders positioned ahead of U. S.
